Christophe Piketty, MD, PhD

home / authors / christophe-piketty-md-phd

Articles

Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PN

Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PN

Emma Andrus, Editor;Christophe Piketty, MD, PhD
February 27th 2025

Christophe Piketty, MD, PHD, provides a deeper look at the promise of nemolizumab in addressing unmet needs faced by patients with atopic dermatitis and prurigo nodularis.

Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally

Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally

Emma Andrus, Editor;Christophe Piketty, MD, PhD
February 26th 2025

Christophe Piketty, MD, PHD, discusses the promising efficacy, novel mechanisms, and patient benefits of nemolizumab in targeting IL-31 for atopic dermatitis and psoriasis.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Published: November 17th 2023 | Updated: March 1st 2025
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Patients with Androgenetic Alopecia Have a Higher Risk of Depression
Published: February 26th 2025 | Updated: March 1st 2025
Patients with Androgenetic Alopecia Have a Higher Risk of Depression
POLL: What Is Your Go-to Treatment for Severe Palmar Hyperhidrosis?
Published: February 19th 2024 | Updated: March 1st 2025
POLL: What Is Your Go-to Treatment for Severe Palmar Hyperhidrosis?
FDA Clears Zabalafin Hydrogel’s Investigational New Drug Application for AD
Published: February 19th 2025 | Updated: March 1st 2025
FDA Clears Zabalafin Hydrogel’s Investigational New Drug Application for AD
How the LIMITLESS Initiative Supports Female Leaders in Dermatology
Published: February 25th 2025 | Updated: March 1st 2025
How the LIMITLESS Initiative Supports Female Leaders in Dermatology
© 2025 MJH Life Sciences

All rights reserved.